UniProt P30657
Proteasome subunit beta type-7 (P30657)
Proteasome subunit beta type-7 (UniProt P30657), EC 3.4.25.1: 542 experimental structures on GenesisL1, 2 ligands bound, 122 pockets. Binding sites, pockets, druggability and 3D structures in GL1X.
- UniProt
- P30657
- Protein
- Proteasome subunit beta type-7
- EC
- 3.4.25.1
- Experimental structures
- 542
- Predicted models
- 0
- Ligands
- 2
- Pockets
- 122 · 23 records with a druggable one
Structures
542 records of P30657 in the MolNFT archive: 542 experimental, 0 predicted.
| Entry | Title | Method | Chains | Ligands | Pockets |
|---|---|---|---|---|---|
| 1FNT | Crystal structure of the 20S proteasome from yeast in complex with the proteasome activator PA26… | x-ray diffraction | N, b | — | — |
| 1FNT | Crystal structure of the 20S proteasome from yeast in complex with the proteasome activator PA26… | x-ray diffraction | N, b | — | — |
| 1G0U | A gated channel into the proteasome core particle | x-ray diffraction | M, 1 | — | — |
| 1G0U | A gated channel into the proteasome core particle | x-ray diffraction | M, 1 | — | — |
| 1G65 | Crystal structure of epoxomicin:20s proteasome reveals a molecular basis for selectivity of… | x-ray diffraction | M, 1 | — | — |
| 1G65 | Crystal structure of EPOXOMICIN:20S proteasome reveals a molecular basis for selectivity of… | x-ray diffraction | M, 1 | — | — |
| 1JD2 | Crystal Structure of the yeast 20S Proteasome:TMC-95A complex: A non-covalent Proteasome Inhibitor | x-ray diffraction | M, T | — | — |
| 1JD2 | Crystal structure of the yeast 20S PROTEASOME:TMC-95A complex: a non- covalent proteasome inhibitor | x-ray diffraction | M, T | — | — |
| 1RYP | Crystal structure of the 20S proteasome from yeast at 2.4 ångströms resolution | x-ray diffraction | N, 2 | — | — |
| 1RYP | Crystal structure of the 20S proteasome from yeast at 2.4 ångströms resolution | x-ray diffraction | N, 2 | — | — |
| 1Z7Q | Crystal structure of the 20s proteasome from yeast in complex with the proteasome activator PA26… | x-ray diffraction | N, b | — | — |
| 1Z7Q | Crystal structure of the 20S proteasome from yeast in complex with the proteasome activator PA26… | x-ray diffraction | N, b | — | — |
| 2F16 | Crystal structure of the yeast 20S proteasome in complex with bortezomib | x-ray diffraction | M, 1 | — | — |
| 2F16 | Crystal structure of the yeast 20S proteasome in complex with bortezomib | x-ray diffraction | M, 1 | — | — |
| 2FAK | Crystal structure of Salinosporamide A in complex with the yeast 20S proteasome | x-ray diffraction | M, 1 | — | — |
| 2FAK | Crystal structure of salinosporamide a in complex with the yeast 20S proteasome | x-ray diffraction | M, 1 | — | — |
| 2GPL | TMC-95 based biphenyl-ether macrocycles: specific proteasome inhibitors | x-ray diffraction | M, 1 | — | — |
| 2GPL | Tmc-95 based biphenyl-ether macrocycles: specific proteasome inhibitors | x-ray diffraction | M, 1 | — | — |
| 2ZCY | yeast 20S proteasome:syringolin A-complex | x-ray diffraction | M, 0 | — | — |
| 2ZCY | Yeast 20S PROTEASOME:SYRINGOLIN a-complex | x-ray diffraction | M, 0 | — | — |
| 3BDM | yeast 20S proteasome:glidobactin A-complex | x-ray diffraction | M, 0 | — | — |
| 3BDM | Yeast 20S PROTEASOME:GLIDOBACTIN a-complex | x-ray diffraction | M, 0 | — | — |
| 3D29 | Proteasome inhibition by fellutamide B | x-ray diffraction | M, 1 | — | — |
| 3DY3 | Crystal structure of yeast 20S proteasome in complex with the epimer form of spirolactacystin | x-ray diffraction | M, 1 | — | — |
| 3DY3 | Crystal structure of yeast 20S proteasome in complex with the epimer form of spirolactacystin | x-ray diffraction | M, 1 | — | — |
| 3DY4 | Crystal structure of yeast 20S proteasome in complex with spirolactacystin | x-ray diffraction | M, 1 | — | — |
| 3DY4 | Crystal structure of yeast 20S proteasome in complex with spirolactacystin | x-ray diffraction | M, 1 | — | — |
| 3E47 | Crystal Structure of the Yeast 20S Proteasome in Complex with Homobelactosin C | x-ray diffraction | M, 1 | — | — |
| 3E47 | Crystal structure of the yeast 20S proteasome in complex with homobelactosin C | x-ray diffraction | M, 1 | — | — |
| 3GPJ | Crystal structure of the yeast 20S proteasome in complex with syringolin B | x-ray diffraction | M, 1 | — | — |
| 3GPJ | Crystal structure of the yeast 20S proteasome in complex with syringolin B | x-ray diffraction | M, 1 | — | — |
| 3GPT | Crystal structure of the yeast 20S proteasome in complex with Salinosporamide derivatives: slow… | x-ray diffraction | M, 1 | — | — |
| 3GPT | Crystal structure of the yeast 20S proteasome in complex with salinosporamide derivatives: slow… | x-ray diffraction | M, 1 | — | — |
| 3GPW | Crystal structure of the yeast 20S proteasome in complex with Salinosporamide derivatives… | x-ray diffraction | M, 1 | — | — |
| 3GPW | Crystal structure of the yeast 20S proteasome in complex with salinosporamide derivatives… | x-ray diffraction | M, 1 | — | — |
| 3HYE | Crystal structure of 20S proteasome in complex with hydroxylated salinosporamide | x-ray diffraction | M, 1 | — | — |
| 3HYE | Crystal structure of 20S proteasome in complex with hydroxylated salinosporamide | x-ray diffraction | M, 1 | — | — |
| 3JCO | Structure of yeast 26S proteasome in M1 state derived from Titan dataset | electron microscopy | 2, 9 | — | — |
| 3JCP | Structure of yeast 26S proteasome in M2 state derived from Titan dataset | electron microscopy | 2, 9 | — | — |
| 3MG0 | Structure of yeast 20S proteasome with bortezomib | x-ray diffraction | M, 1 | — | — |
| 3MG0 | Structure of yeast 20S proteasome with bortezomib | x-ray diffraction | M, 1 | — | — |
| 3MG4 | Structure of yeast 20S proteasome with Compound 1 | x-ray diffraction | M, 1 | — | — |
| 3MG4 | Structure of yeast 20S proteasome with compound 1 | x-ray diffraction | M, 1 | — | — |
| 3MG6 | Structure of yeast 20S open-gate proteasome with Compound 6 | x-ray diffraction | M, 1 | — | — |
| 3MG6 | Structure of yeast 20S open-gate proteasome with compound 6 | x-ray diffraction | M, 1 | — | — |
| 3MG7 | Structure of yeast 20S open-gate proteasome with Compound 8 | x-ray diffraction | M, 1 | — | — |
| 3MG7 | Structure of yeast 20S open-gate proteasome with compound 8 | x-ray diffraction | M, 1 | — | — |
| 3MG8 | Structure of yeast 20S open-gate proteasome with Compound 16 | x-ray diffraction | M, 1 | — | — |
| 3MG8 | Structure of yeast 20S open-gate proteasome with compound 16 | x-ray diffraction | M, 1 | — | — |
| 3NZJ | Crystal structure of yeast 20S proteasome in complex with ligand 2a | x-ray diffraction | M, 1 | — | — |
| 3NZJ | Crystal structure of yeast 20S proteasome in complex with ligand 2A | x-ray diffraction | M, 1 | — | — |
| 3NZW | Crystal structure of the yeast 20S proteasome in complex with 2b | x-ray diffraction | M, 1 | — | — |
| 3NZW | Crystal structure of the yeast 20S proteasome in complex with 2B | x-ray diffraction | M, 1 | — | — |
| 3NZX | Crystal structure of the yeast 20S proteasome in complex with ligand 2c | x-ray diffraction | M, 1 | — | — |
| 3NZX | Crystal structure of the yeast 20S proteasome in complex with ligand 2C | x-ray diffraction | M, 1 | — | — |
| 3OEU | Structure of yeast 20S open-gate proteasome with Compound 24 | x-ray diffraction | M, 1 | — | — |
| 3OEU | Structure of yeast 20S open-gate proteasome with compound 24 | x-ray diffraction | M, 1 | — | — |
| 3OEV | Structure of yeast 20S open-gate proteasome with Compound 25 | x-ray diffraction | M, 1 | — | — |
| 3OEV | Structure of yeast 20S open-gate proteasome with compound 25 | x-ray diffraction | M, 1 | — | — |
| 3OKJ | Alpha-keto-aldehyde binding mechanism reveals a novel lead structure motif for proteasome inhibition | x-ray diffraction | M, 1 | — | — |
482 records more on the page itself.
Ligands
Elsewhere
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.